Dynamic accumulation of plasmacytoid dendritic cells in lymph nodes is regulated by interferon-β

Blood

Volumn 114, Issue 13, 2009, Pages 2623-2631

  Gao, Yunfei ^a   Majchrzak Kita, Beata ^a,b   Fish, Eleanor N ^a,b   Gommerman, Jennifer L ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CD69 ANTIGEN; FINGOLIMOD; RECOMBINANT ALPHA INTERFERON; RECOMBINANT BETA INTERFERON; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE 4; UNCLASSIFIED DRUG; ALPHA INTERFERON; LEUKOCYTE ANTIGEN; RECOMBINANT PROTEIN; T LYMPHOCYTE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; EX VIVO STUDY; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; IMMUNOSURVEILLANCE; IN VIVO STUDY; LYMPH NODE; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; UPREGULATION; VIRUS INFECTION; ANIMAL; BLOOD; C57BL MOUSE; CELL CULTURE; CELL MOTION; CYTOLOGY; DRUG EFFECT; GENETICS; IMMUNOLOGY; LYMPHOID TISSUE; METABOLISM; MOUSE MUTANT; ORTHOMYXOVIRUS; ORTHOMYXOVIRUS INFECTION; PHYSIOLOGY; VIROLOGY;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL MOVEMENT; CELLS, CULTURED; DENDRITIC CELLS; INTERFERON-ALPHA; INTERFERON-BETA; LYMPH NODES; LYMPHOID TISSUE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; RECOMBINANT PROTEINS;

EID: 70350490572     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-10-183301     Document Type: Article

References (50)

1. Cyster JG. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu Rev Immunol. 2005;23127-23159.
2. Schwab SR, Cyster JG. Finding a way out: lymphocyte egress from lymphoid organs. Nat Immunol. 2007;8(12):1295-1301.
3. Gresser I, Guy-Grand D, Maury C, Maunoury MT. Interferon induces peripheral lymphadenopathy in mice. J Immunol. 1981;127(4):1569-1575.
4. Shiow LR, Rosen DB, Brdickova N, et al. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature. 2006;440(7083):540-544.
5. Gilliet M, Cao W, Liu YJ. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol. 2008;8(8):594-606.
6. Colonna M, Trinchieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nat Immunol. 2004;5(12):1219-1226.
7. Krug A, French AR, Barchet W, et al. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity. 2004;21(1):107-119.
8. Jego G, Palucka AK, Blanck JP, Chalouni C, Pascual V, Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity. 2003;19(2):225-234.
9. Poeck H, Wagner M, Battiany J, et al. Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. Blood. 2004;103(8):3058-3064.
10. Cella M, Facchetti F, Lanzavecchia A, Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol. 2000;1(4):305-310.
11. Kadowaki N, Antonenko S, Lau JY, Liu YJ. Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J Exp Med. 2000;192(2):219-226.
12. + T cells: a new role for plasmacytoid dendritic cells in adaptive immunity. Blood. 2003;101(9):3520-3526.
13. Hoeffel G, Ripoche AC, Matheoud D, et al. Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity. 2007;27(3):481-492.
14. Cella M, Jarrossay D, Facchetti F, et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med. 1999;5(8):919-923.
15. Diacovo TG, Blasius AL, Mak TW, Cella M, Colonna M. Adhesive mechanisms governing interferon-producing cell recruitment into lymph nodes. J Exp Med. 2005;202(5):687-696.
16. Yoneyama H, Matsuno K, Zhang Y, et al. Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int Immunol. 2004;16(7):915-928.
17. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science. 1996;272(5258):60-66.
18. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18767-18811.
19. Pascale F, Contreras V, Bonneau M, et al. Plasmacytoid dendritic cells migrate in afferent skin lymph. J Immunol. 2008;180(9):5963-5972.
20. Vanbervliet B, Bendriss-Vermare N, Massacrier C, et al. The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12. J Exp Med. 2003;198(5):823-830.
21. Zou W, Machelon V, Coulomb-L'Hermin A, et al. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med. 2001;7(12):1339-1346.
22. Penna G, Sozzani S, Adorini L. Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J Immunol. 2001;167(4):1862-1866.
23. Li L, Liu S, Zhang T, Pan W, Yang X, Cao X. Splenic stromal microenvironment negatively regulates virus-activated plasmacytoid dendritic cells through TGF-beta. J Immunol. 2008;180(5):2951-2956.
24. Hardy MP, Owczarek CM, Jermiin LS, Ejdeback M, Hertzog PJ. Characterization of the type I interferon locus and identification of novel genes. Genomics. 2004;84(2):331-345.
25. Asselin-Paturel C, Brizard G, Chemin K, et al. Type I interferon dependence of plasmacytoid dendritic cell activation and migration. J Exp Med. 2005;201(7):1157-1167.
26. Deonarain R, Alcami A, Alexiou M, Dallman MJ, Gewert DR, Porter AC. Impaired antiviral response and alpha/beta interferon induction in mice lacking beta interferon. J Virol. 2000;74(7):3404-3409.
27. Deonarain R, Verma A, Porter AC, Gewert DR, Platanias LC, Fish EN. Critical roles for IFN-beta in lymphoid development, myelopoiesis, and tumor development: links to tumor necrosis factor alpha. Proc Natl Acad Sci U S A. 2003;100(23):13453-13458.
28. McCarthy DD, Chiu S, Gao Y, Summers-deLuca LE, Gommerman JL. BAFF induces a hyper-IgA syndrome in the intestinal lamina propria concomitant with IgA deposition in the kidney independent of LIGHT. Cell Immunol. 2006;241(2):85-94.
29. Mandala S, Hajdu R, Bergstrom J, et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science. 2002;296(5566):346-349.
30. Brinkmann V, Davis MD, Heise CE, et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem. 2002;277(24):21453- 21457.
31. Chiba K, Yanagawa Y, Masubuchi Y, et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J Immunol. 1998;160(10):5037-5044.
32. Sanna MG, Liao J, Jo E, et al. Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. J Biol Chem. 2004;279(14):13839-13848.
33. Pham TH, Okada T, Matloubian M, Lo CG, Cyster JG. S1P1 receptor signaling overrides retention mediated by G alpha i-coupled receptors to promote T cell egress. Immunity. 2008;28(1):122-133.
34. Kamphuis E, Junt T, Waibler Z, Forster R, Kalinke U. Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia. Blood. 2006;108(10):3253-3261.
35. Korngold R, Blank KJ, Murasko DM. Effect of interferon on thoracic duct lymphocyte output: induction with either poly I:poly C or vaccinia virus. J Immunol. 1983;130(5):2236-2240.
36. Walzer T, Chiossone L, Chaix J, et al. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat Immunol. 2007;8(12):1337-1344.
37. Randolph GJ, Ochando J, Partida-Sanchez S. Migration of dendritic cell subsets and their precursors. Annu Rev Immunol. 2008;26293-26316.
38. Cavanagh LL, Bonasio R, Mazo IB, et al. Activation of bone marrow-resident memory T cells by circulating, antigen-bearing dendritic cells. Nat Immunol. 2005;6(10):1029-1037.
39. Dandie GW, Watkins FY, Ragg SJ, Holloway PE, Muller HK. The migration of Langerhans' cells into and out of lymph nodes draining normal, carcinogen and antigen-treated sheep skin. Immunol Cell Biol. 1994;72(1):79-86.
40. Bell EB. Antigen-laden cells in thoracic duct lymph. Implications for adoptive transfer experiments. Immunology. 1979;38(4):797-808.
41. Anderson AO,Warren JT, Gasser DL. Presence of lymphoid dendritic cells in thoracic duct lymph from Lewis rats. Transplant Proc. 1981;13(2):1460-1468.
42. Shigematsu H, Reizis B, Iwasaki H, et al. Plasmacytoid dendritic cells activate lymphoid-specific genetic programs irrespective of their cellular origin. Immunity. 2004;21(1):43-53.
43. Yrlid U, Cerovic V, Milling S, et al. Plasmacytoid dendritic cells do not migrate in intestinal or hepatic lymph. J Immunol. 2006;177(9):6115-6121.
44. Gräler MH, Grosse R, Kusch A, Kremmer E, Gudermann T, Lipp M. The sphingosine 1-phosphate receptor S1P4 regulates cell shape and motility via coupling to Gi and G12/13. J Cell Biochem. 2003;89(3):507-519.
45. Matsuyuki H, Maeda Y, Yano K, et al. Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P. Cell Mol Immunol. 2006;3(6):429-437.
46. Wang W, Graeler MH, Goetzl EJ. Type 4 sphingosine 1-phosphate G protein-coupled receptor (S1P4) transduces S1P effects on T-cell proliferation and cytokine secretion without signaling migration. FASEB J. 2005;19(12):1731-1733.
47. Jaitin DA, Roisman LC, Jaks E, et al. Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IF-NAR1 is functionally similar to IFN-beta. Mol Cell Biol. 2006;26(5):1888- 1897.
48. Gilli F, Valentino P, Caldano M, et al. Expression and regulation of IFNalpha/beta receptor in IFN-beta-treated patients with multiple sclerosis. Neurology. 2008;71(24):1940-1947.
49. O'Connor P, Comi G, Montalban X, et al. Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study. Neurology. 2009;72(1):73-79.
50. Bailey-Bucktrout SL, Caulkins SC, Goings G, Fischer JA, Dzionek A, Miller SD. Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis. J Immunol. 2008;180(10):6457-6461.